Growth Metrics

Pfizer (PFE) Return on Capital Employed Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 -2,232.00
Sep 28, 2025 -2,135.00
Jun 29, 2025 -1,574.00
Mar 30, 2025 -1,001.00
Sep 29, 2024 -2,012.00
Jun 30, 2024 -1,978.00
Mar 31, 2024 -2,339.00
Dec 31, 2023 -3,098.00
Oct 1, 2023 -2,762.00
Jul 2, 2023 -1,744.00
Apr 2, 2023 -880.00
Oct 2, 2022 781.00
Jul 3, 2022 -220.00
Apr 3, 2022 -668.00
Oct 3, 2021 -641.00
Jul 4, 2021 -1,575.00
Apr 4, 2021 -1,749.00
Sep 27, 2020 -2,069.00
Jun 28, 2020 -1,686.00
Mar 29, 2020 -1,064.00
Dec 31, 2019 -60.00
Sep 29, 2019 -129.00
Jun 30, 2019 -369.00
Mar 31, 2019 -483.00
Dec 31, 2018 -547.00
Sep 30, 2018 631.00
Jul 1, 2018 1,127.00
Apr 1, 2018 1,303.00
Dec 31, 2017 1,601.00
Oct 1, 2017 1,622.00
Jul 2, 2017 1,576.00
Apr 2, 2017 1,561.00
Dec 31, 2016 1,614.00
Oct 2, 2016 1,868.00
Jul 3, 2016 1,978.00
Apr 3, 2016 1,929.00
Dec 31, 2015 1,745.00
Sep 27, 2015 1,312.00
Jun 28, 2015 978.00
Mar 29, 2015 699.00
Dec 31, 2014 233.00
Sep 28, 2014 -172.00